- Home
- BEAT vs DXLG Comparison
BEAT vs DXLG Comparison
Compare BEAT & DXLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEAT
- DXLG
- Stock Information
- Founded
- BEAT 2015
- DXLG 1976
- Country
- BEAT United States
- DXLG United States
- Employees
- BEAT N/A
- DXLG N/A
- Industry
- BEAT Retail: Computer Software & Peripheral Equipment
- DXLG Clothing/Shoe/Accessory Stores
- Sector
- BEAT Technology
- DXLG Consumer Discretionary
- Exchange
- BEAT Nasdaq
- DXLG Nasdaq
- Market Cap
- BEAT 51.1M
- DXLG 55.4M
- IPO Year
- BEAT 2021
- DXLG 1987
- Fundamental
- Price
- BEAT $1.30
- DXLG $1.20
- Analyst Decision
- BEAT Buy
- DXLG Strong Buy
- Analyst Count
- BEAT 1
- DXLG 1
- Target Price
- BEAT $8.00
- DXLG $2.50
- AVG Volume (30 Days)
- BEAT 169.5K
- DXLG 667.8K
- Earning Date
- BEAT 08-13-2025
- DXLG 08-28-2025
- Dividend Yield
- BEAT N/A
- DXLG N/A
- EPS Growth
- BEAT N/A
- DXLG N/A
- EPS
- BEAT N/A
- DXLG N/A
- Revenue
- BEAT N/A
- DXLG $457,059,000.00
- Revenue This Year
- BEAT N/A
- DXLG N/A
- Revenue Next Year
- BEAT N/A
- DXLG $3.56
- P/E Ratio
- BEAT N/A
- DXLG N/A
- Revenue Growth
- BEAT N/A
- DXLG N/A
- 52 Week Low
- BEAT $1.17
- DXLG $0.90
- 52 Week High
- BEAT $3.48
- DXLG $3.93
- Technical
- Relative Strength Index (RSI)
- BEAT 36.38
- DXLG 58.36
- Support Level
- BEAT $1.17
- DXLG $1.10
- Resistance Level
- BEAT $1.62
- DXLG $1.23
- Average True Range (ATR)
- BEAT 0.11
- DXLG 0.07
- MACD
- BEAT -0.02
- DXLG 0.01
- Stochastic Oscillator
- BEAT 21.96
- DXLG 84.62
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.
About DXLG Destination XL Group Inc.
Destination XL Group Inc is a retailer of branded and Tall men's clothing and shoes in the United States. It also sells products across the world. The company sells its products under the trade names Destination XL, DXL, DXL Men's Apparel, DXL outlets, Casual Male XL, and Casual Male XL outlets. The company has two principal operating segments: Store, and Direct business.